Preliminary reliability of the FACT-RNT in standard-of-care Lu-PSMA therapy of metastatic castration-resistant prostate cancer.

被引:0
|
作者
Gudenkauf, Lisa Marie
Murthy, Vishnu
Lam, Ethan C.
Li, Xiaoyin
Gardner, Linda
Tagawa, Scott T.
Dicker, Adam P.
Cella, David
Czernin, Johannes
Calais, Jeremie
Gonzalez, Brian D.
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Univ Calif Los Angeles, Mt House, CA USA
[3] Univ Calif Los Angeles, Ahmanson Translat Theranost Div, Los Angeles, CA USA
[4] Univ Calif Los Angeles, Los Angeles, CA USA
[5] New York Presbyterian Hosp, Div Hematol & Med Oncol, Weill Cornell Med, New York, NY USA
[6] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA USA
[7] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA
[8] Univ Calif Los Angeles, Dept Nucl Med, Los Angeles, CA USA
关键词
261-492-199; 130-3426-3529; 261-492-6491; 283-2494-5577-2829-12292; 261-436; 2;
D O I
10.1200/JCO.2024.42.4_suppl.99
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [21] [177Lu]-PSMA-617 radionuclide therapy in patients with metastatic castration-resistant prostate cancer
    Rahbar, Kambiz
    Ahmadzadehfar, Hojjat
    Seifert, Robert
    Boegemann, Martin
    LANCET ONCOLOGY, 2018, 19 (08): : E371 - E371
  • [22] Community oncologists' perceptions of and barriers to access for 177LU-PSMA-617 in metastatic castration-resistant prostate cancer.
    Gajra, Ajeet
    Estupinian, Ricardo
    Fortier, Stephanie
    Jeune-Smith, Yolaine
    Feinberg, Bruce A.
    Vaishampayan, Ulka N.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [23] 177Lu-PSMA-RLT of metastatic castration-resistant prostate cancer: limitations and improvements
    Jianpeng Cao
    Yue Chen
    Mei Hu
    Wei Zhang
    Annals of Nuclear Medicine, 2021, 35 : 861 - 870
  • [24] 177Lu-PSMA-RLT of metastatic castration-resistant prostate cancer: limitations and improvements
    Cao, Jianpeng
    Chen, Yue
    Hu, Mei
    Zhang, Wei
    ANNALS OF NUCLEAR MEDICINE, 2021, 35 (08) : 861 - 870
  • [25] Matched-pair analysis of [177Lu]Lu-PSMA I&T and [177Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
    Philipp E. Hartrampf
    Franz-Xaver Weinzierl
    Andreas K. Buck
    Steven P. Rowe
    Takahiro Higuchi
    Anna Katharina Seitz
    Hubert Kübler
    Andreas Schirbel
    Markus Essler
    Ralph A. Bundschuh
    Rudolf A. Werner
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 3269 - 3276
  • [26] Review of 177Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer
    Sun, Michael
    Niaz, Muhammad O.
    Nelson, Adlai
    Skafida, Myrto
    Niaz, Muhammad J.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (06)
  • [27] Matched-pair analysis of [177Lu]Lu-PSMA I&T and [177Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
    Hartrampf, Philipp E.
    Weinzierl, Franz-Xaver
    Buck, Andreas K.
    Rowe, Steven P.
    Higuchi, Takahiro
    Seitz, Anna Katharina
    Kuebler, Hubert
    Schirbel, Andreas
    Essler, Markus
    Bundschuh, Ralph A.
    Werner, Rudolf A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (09) : 3269 - 3276
  • [28] Combining enzalutamide and [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer
    Houede, Nadine
    Hebert, Kevin
    LANCET ONCOLOGY, 2024, 25 (05): : 531 - 533
  • [29] PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617
    Kratochwil, Clemens
    Giesel, Frederik L.
    Stefanova, Melsa
    Benesova, Martina
    Bronzel, Marcus
    Afshar-Oromieh, Ali
    Mier, Walter
    Eder, Matthias
    Kopka, Klaus
    Haberkorn, Uwe
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (08) : 1170 - 1176
  • [30] Early biochemical and radiographic response after one cycle of [177Lu]Lu-PSMA I&T radioligand therapy in metastatic castration-resistant prostate cancer patients
    Wojciech Cytawa
    Robin Hendel
    Bartłomiej Tomasik
    Franz-Xaver Weinzierl
    Thorsten Bley
    Jacek Jassem
    Andreas Schirbel
    Andreas K. Buck
    Ralph A. Bundschuh
    Philipp E. Hartrampf
    Rudolf A. Werner
    Constantin Lapa
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 3765 - 3776